Table 2.

Biometric characteristics of C57BL/6 mice 36 days following a myocardial infarction

	Sham	MI+PBS	MI+MSC
Fasting plasma glucose, mM	9.05 ± 0.31	8.18 ± 0.37	8.43 ± 0.33
Fasting plasma NEFA, mM	0.9 ± 0.05	0.94 ± 0.05	1.0 ± 0.05
Experimental plasma insulin, μU/ml	103.87 ± 22.32	90.25 ± 13.58	91.67 ± 12.40
Body weight, g	26.61 ± 0.85	25.77 ± 0.98	27.9 ± 0.55
Muscle, %	90.88 ± 0.88	90.03 ± 0.41	89.15 ± 0.94
Fat, %	7.66 ± 0.68	7.93 ± 0.32	8.59 ± 0.97
Free fluid, %	1.46 ± 0.36	2.04 ± 0.20	2.21 ± 0.17

Values are means ± SE; n = 12–13 mice/group for plasma glucose; n = 11–12 for plasma NEFA, n = 6–9 for experimental plasma insulin, n = 7–9 for body weight, and n = 11–15 for body composition measurements. NEFA, nonesterified fatty acid.